Business Description
Fortis Malar Hospitals Ltd
ISIN : INE842B01015
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.81 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 16.18 | |||||
Beneish M-Score | -1.55 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.2 | |||||
3-Year EBITDA Growth Rate | 93.7 | |||||
3-Year EPS without NRI Growth Rate | 17.7 | |||||
3-Year FCF Growth Rate | -90.4 | |||||
3-Year Book Growth Rate | 7.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.88 | |||||
9-Day RSI | 39 | |||||
14-Day RSI | 44.56 | |||||
6-1 Month Momentum % | -1.49 | |||||
12-1 Month Momentum % | 5.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.94 | |||||
Quick Ratio | 4.94 | |||||
Cash Ratio | 4.93 | |||||
Days Inventory | 106.19 | |||||
Days Sales Outstanding | 40 | |||||
Days Payable | 837.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 72.49 | |||||
Dividend Payout Ratio | 1.59 | |||||
Forward Dividend Yield % | 72.49 | |||||
5-Year Yield-on-Cost % | 72.49 | |||||
Shareholder Yield % | 72.49 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 82.13 | |||||
Operating Margin % | -25.16 | |||||
Net Margin % | 218.24 | |||||
FCF Margin % | -41.85 | |||||
ROE % | 75.62 | |||||
ROA % | 53.43 | |||||
ROIC % | -18.34 | |||||
3-Year ROIIC % | -2.89 | |||||
ROC (Joel Greenblatt) % | 127.7 | |||||
ROCE % | 71.43 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 2.19 | |||||
PE Ratio without NRI | 2.19 | |||||
Shiller PE Ratio | 32.48 | |||||
PEG Ratio | 0.06 | |||||
PS Ratio | 4.79 | |||||
PB Ratio | 3.68 | |||||
Price-to-Tangible-Book | 3.68 | |||||
EV-to-EBIT | 0.03 | |||||
EV-to-EBITDA | 0.03 | |||||
EV-to-Revenue | 0.07 | |||||
EV-to-FCF | -0.17 | |||||
Price-to-Projected-FCF | 1.78 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.09 | |||||
Price-to-Graham-Number | 0.6 | |||||
Price-to-Net-Current-Asset-Value | 4.06 | |||||
Price-to-Net-Cash | 4.07 | |||||
Earnings Yield (Greenblatt) % | 3333.33 | |||||
FCF Yield % | -8.74 | |||||
Forward Rate of Return (Yacktman) % | 16.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Fortis Malar Hospitals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 229.429 | ||
EPS (TTM) (₹) | 26.72 | ||
Beta | 0.12 | ||
Volatility % | 189.64 | ||
14-Day RSI | 44.56 | ||
14-Day ATR (₹) | 2.658669 | ||
20-Day SMA (₹) | 60.483 | ||
12-1 Month Momentum % | 5.39 | ||
52-Week Range (₹) | 44 - 107.94 | ||
Shares Outstanding (Mil) | 18.74 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fortis Malar Hospitals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fortis Malar Hospitals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Fortis Malar Hospitals Ltd Frequently Asked Questions
What is Fortis Malar Hospitals Ltd(BOM:523696)'s stock price today?
When is next earnings date of Fortis Malar Hospitals Ltd(BOM:523696)?
Does Fortis Malar Hospitals Ltd(BOM:523696) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |